InsidersTradesSigma
Explore the detailed record of transactions filed by Haskel William M., Dirigeant. Officer active across 1 companies, notably Paratek Pharmaceuticals, Inc.. Aggregated, 7 disclosures have been published. Total volume traded: €38k. The latest transaction was disclosed on 15 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
7 of 7 declarations
William M. Haskel is the CLO, General Counsel, and Secretary of Paratek Pharmaceuticals, Inc. In this role, he is responsible for the company's legal affairs and regulatory compliance. His expertise in business law is essential for Paratek's strategy.